VLGAI | 29- to 31-wk stratum | ELGAI | ||||
---|---|---|---|---|---|---|
Period 1 N = 91 | Period 2 N = 72 | Period 1 N = 43 | Period 2 N = 30 | Period 1 N = 48 | Period 2 N = 42 | |
MV in the first 72 h, n (%) | 72 (79) | 41 (57)*## | 28 (65) | 11 (37)*# | 44 (92) | 30 (71)* |
Duration of MV within the first 72 h, h (median) [1st Qu; 3rd Qu] | 13 [3–48] | 7*# [0–30] | 8 [0–17] | 0 [0–13] | 45 [9–72] | 13** [0–43] |
Duration of MV, d (median) [1st Qu; 3rd Qu] | 1 [0–6] | 1 [0–6] | 0 [0–1] | 0 [0–1] | 5 [1–24] | 4 [0–10] |
Duration of NIV, d (median) [1st Qu; 3rd Qu] | 27 [6–40] | 27 [8–35] | 13 [3–28] | 13 [7–25] | 37 [26–45] | 32 [23–39] |
HFO, n (%) | 26 (29) | 34 (48)*## | 2 (5) | 6 (21)# | 24 (50) | 28 (67)# |
2nd dose of Surfactant, n (%) | 19 (21) | 6 (8)*## | 2 (5) | 1 (3) | 17 (35) | 5 (12)*## |
INSURE Procedure, n (%) | 2 (2) | 11 (15)*## | 0 (0) | 5 (17)* | 2 (4) | 6 (14) |
Postnatal Corticosteroids, n (%) | 28 (31) | 9 (13)*## | 3 (7) | 1 (3) | 25 (52) | 8 (19)*## |